Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in from biologics discovery and development through to production and supply chain management.

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Vaccines

3-Dose Hepatitis B Vaccine Offers Full Protection for People with HIV

Phase III clinical trials from the University of Cincinnati have shown seroprotection in 100% of HIV-positive participants after a 3-dose regimen of the HEPLISAV-B vaccine.
Read More
Biologics Analysis

Mass Spectrometry: Shortening Time Scales and Progressing Towards Automation

Discover the top bioanalysis presentations from Biologics UK 2022.
Read More
Proteins & Antibodies

Oxford Global's R&D Key 40 Stories 2022

Download a copy of the R&D Key 40 Stories 2022 eBook today.
Read More
Bispecifics

Gilead Pay Big Bucks for MacroGenics' Blood-Cancer Targeting Bispecific

Gilead announced a $1.7 billion licence-option deal for MacroGenics’ MGD024 bispecific once Phase I trials conclude.
Read More
Biologics Analysis

Turbocharging Potency Assays – Challenges and Opportunities from Multispecific Drug Modalities

The development of multispecific drugs is an inherently complex and challenging process. Barbara Hebeis of AstraZeneca talks us through challenges surrounding the development of appropriate potency assays, and the opportunities the field offers.
Read More
Proteins & Antibodies

The STING in Immunotherapy’s Tail

Research from the University of North Carolina into STING agonists provides new insights for immunotherapy cancer treatments.
Read More
Proteins & Antibodies

Eisai’s Alzheimer's Drug Offers New Hope

Eisai’s new drug lecanemab has shown small but significant benefits for people with early Alzheimer’s disease.
Read More
Proteins & Antibodies

Is Your WASH Causing Inflammation? Protein Complex Linked to Inflammatory Conditions

Research published by the Scripps Research Institute reveals the WASH protein complex as a crucial factor in neutrophil-triggered inflammation.
Read More
Vaccines

Why We Develop Autoimmunity: Hyperstimulation of Genetically Prone Subjects

Professor Yehuda Shoenfeld explains his findings in establishing links between genetic predisposition and hyperstimulation of the immune system and how this may help us better understand the development of autoimmunity.
Read More
Vaccines

Advanced Vaccine Platforms & Technologies

Wieslaw Swietnicki, Head of Biosynthesis and Bioengineering Group at the Institute of Industrial Organic Chemistry, leads a discussion on the current outlook for advanced vaccine platforms, technologies, and development.
Read More
Vaccines

Pfizer’s Pneumococcal Vaccine Shows Great Promise in European Study

Pfizer’s new PCV candidate is set to become the most effective protector against pneumococcal infections for infants.
Read More
Peptides

FDA Gives Green Light to Long-Awaited Botox Competitor

Competition between cosmetic treatments begins.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biologics